Medigene AG (WBO:MDG1) Operating Cash Flow per Share : €-0.59 (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medigene AG Operating Cash Flow per Share?

Medigene AG's operating cash flow per share for the six months ended in Dec. 2023 was €-0.27. Medigene AG's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.59.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Medigene AG was -226.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Medigene AG's Operating Cash Flow per Share or its related term are showing as below:

WBO:MDG1' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -131.6 Med: 1.25 Max: 47.1
Current: 15.2

During the past 13 years, Medigene AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.10% per year. The lowest was -131.60% per year. And the median was 1.25% per year.

WBO:MDG1's 3-Year OCF Growth Rate is ranked better than
61.8% of 1241 companies
in the Biotechnology industry
Industry Median: 3.7 vs WBO:MDG1: 15.20

Medigene AG Operating Cash Flow per Share Historical Data

The historical data trend for Medigene AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Operating Cash Flow per Share Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.64

-0.96

-0.42

0.46

-0.59

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.13	0.67	-0.21	-0.31	-0.27

Competitive Comparison of Medigene AG's Operating Cash Flow per Share

For the Biotechnology subindustry, Medigene AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medigene AG's Price-to-Operating-Cash-Flow falls into.

Medigene AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Medigene AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-15.119	/	25.866
	=	-0.58

Medigene AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-7.085	/	25.866
	=	-0.27

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.59

Medigene AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Medigene AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (WBO:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines